The Trendlines Group’s portfolio company MediValve has received CE Mark clearance for its acWire guidewire, to facilitate the accurate placement and alignment of medical devices in the cardiovascular system during diagnostic and interventional procedures.

MediValve received this approval following review of a technical file submission by the Institute for Testing and Certification.

The acWire guidewire is a single-use, fully disposable device utilising shape-memory alloy technology intended to enable identification of cardiovascular structures during standard flouroscopic imaging.

It is designed for use with all currently available trans-catheter aortic-valve implantation (TAVI) systems.

Without changing the standard TAVI implant procedure, acWire provides the cardiologist with a continuous, clear, and precise landmark where to implant the prosthetic valve.

According to the company, the device relies on latest standard methods and techniques that are used by interventional cardiologists to access the cardiovascular system.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.
"acWire has been designed to shorten procedure time, reduce usage of radiation and contrast media, and improve clinical outcomes."

Once directed to a selected cardiovascular location, acWire is deformable under fluoroscopy to identify a desired specific anatomical landmark for subsequent therapeutic treatment by the clinician.

acWire has been designed to shorten procedure time, reduce usage of radiation and contrast media, and improve clinical outcomes.

MediValve CEO Assaf Klein said: "We anticipate significant clinical interest for this innovative technology. This is the first in a series of regulatory applications while we continue our development of several additional acWire products."

MediValve has already filed 510(k) application with the US Food and Drug Administration for the acWire system.

Image: The MediValve acWire Guidewire is a single-use, fully disposable medical device. Photo: courtesy of Yaddah.